1. Home
  2. PPBT vs RDHL Comparison

PPBT vs RDHL Comparison

Compare PPBT & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • RDHL
  • Stock Information
  • Founded
  • PPBT 2010
  • RDHL 2009
  • Country
  • PPBT Israel
  • RDHL Israel
  • Employees
  • PPBT N/A
  • RDHL N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • RDHL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PPBT Health Care
  • RDHL Health Care
  • Exchange
  • PPBT Nasdaq
  • RDHL Nasdaq
  • Market Cap
  • PPBT 8.7M
  • RDHL 8.2M
  • IPO Year
  • PPBT N/A
  • RDHL N/A
  • Fundamental
  • Price
  • PPBT $3.10
  • RDHL $5.23
  • Analyst Decision
  • PPBT Strong Buy
  • RDHL
  • Analyst Count
  • PPBT 2
  • RDHL 0
  • Target Price
  • PPBT $126.50
  • RDHL N/A
  • AVG Volume (30 Days)
  • PPBT 28.8K
  • RDHL 10.4K
  • Earning Date
  • PPBT 03-04-2025
  • RDHL 04-07-2025
  • Dividend Yield
  • PPBT N/A
  • RDHL N/A
  • EPS Growth
  • PPBT N/A
  • RDHL N/A
  • EPS
  • PPBT N/A
  • RDHL N/A
  • Revenue
  • PPBT N/A
  • RDHL $3,707,000.00
  • Revenue This Year
  • PPBT N/A
  • RDHL $224.90
  • Revenue Next Year
  • PPBT N/A
  • RDHL $82.69
  • P/E Ratio
  • PPBT N/A
  • RDHL N/A
  • Revenue Growth
  • PPBT N/A
  • RDHL N/A
  • 52 Week Low
  • PPBT $2.00
  • RDHL $5.20
  • 52 Week High
  • PPBT $20.60
  • RDHL $20.28
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 41.53
  • RDHL 31.92
  • Support Level
  • PPBT $2.90
  • RDHL $5.52
  • Resistance Level
  • PPBT $3.20
  • RDHL $5.71
  • Average True Range (ATR)
  • PPBT 0.21
  • RDHL 0.27
  • MACD
  • PPBT 0.00
  • RDHL -0.04
  • Stochastic Oscillator
  • PPBT 42.19
  • RDHL 2.38

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

Share on Social Networks: